Epicentre Health Research is proud to announce that they are now supplying the Asanté™ HIV-1 Rapid Recency® Assay to South Africa. This exciting development is a huge step forward in the fight against HIV/AIDS and will make a significant impact in the lives of millions of South Africans.
Why Is Recency Testing Important In The Fight Against HIV?
South Africa is one of the countries most affected by the HIV/AIDS epidemic, with an estimated 7 million people living with the virus.
The Asanté™ HIV-1 Rapid Recency® Assay is a cutting-edge diagnostic tool that provides rapid and accurate results for the detection of recent HIV infections.
This test is used only for research purposes, but is particularly useful for identifying whether individuals are newly infected with the virus. This means that it allows for earlier treatment and intervention, which can lead to better health outcomes and reduced transmission rates.
How The Asanté™ HIV-1 Rapid Recency® Assay Works
Advantages of The Asanté™ HIV-1 Rapid Recency® Assay
✔ Easier, faster & more convenient to use.
✔ Real-time surveillance of new HIV-1 infections to inform resource management.
✔ Evaluating the impact of HIV intervention programs on new infections.
✔ Identifying populations at risk for targeting HIV vaccine trials and monitor the effectiveness of vaccine candidates.
✔ Detecting new “hot spots” of infection for targeted prevention programs.
Epicentre Now Supplying The Asanté™ HIV-1 Rapid Recency® Assay in South Africa
The Asanté™ HIV-1 Rapid Recency® Assay is a cutting-edge tool for detecting recent HIV infections, and its arrival in South Africa marks a significant step forward in the country’s fight against the HIV/AIDS epidemic. Epicentre is commited to providing high-quality healthcare solutions, this makes us uniquely positioned to bring The Asanté™ HIV-1 Rapid Recency® Assay to the South African market and make a meaningful impact on public health. Our expertise in delivering innovative solutions and dedicated team of healthcare professionals will ensure that The Asanté™ HIV-1 Rapid Recency® Assay is available and accessible to those who need it most.
The Future of HIV Recency Testing in South Africa with The Asanté™ HIV-1 Rapid Recency® Assay
The Asanté™ HIV-1 Rapid Recency® Assay also has the potential to reduce the overall cost of HIV testing and treatment, as it eliminates the need for multiple, expensive laboratory tests. Ultimately, the availability of The Asanté™ HIV-1 Rapid Recency® Assay in South Africa represents a major step forward in the country’s fight against HIV/AIDS and will have a positive impact on the health and well-being of its population.
Like Our Articles?
If you want to read more articles like this, join our monthly newsletter! We release insider info on what the health research industry is taking a look at each month.
Your Walk-in Lab Partner
072 843 7564
